45 CFR § 180 compliance
C · 70
This hospital published part of what § 180 requires.
●Machine-readable file published
○Gross / standard charges
○Discounted cash price
●Payer-specific negotiated rates
●Min / max negotiated charges
●Free, public, no login required
Procedures listed
15,536
Insurances with rates
4
CPT / HCPCS codes
7,861
Source MRF
Most expensive procedures (gross)
| Code | Description | Gross | Cash | Min payer | Max payer | # insurers |
|---|---|---|---|---|---|---|
| RX-199157 | TREMELIMUMAB-ACTL 20 MG/ML INTRAVENOUS SOLUTION | $171,760 | $111,644 | — | — | 0 |
| RX-180899 | OCRELIZUMAB 30 MG/ML INTRAVENOUS SOLUTION | $85,703 | $55,707 | — | — | 0 |
| 36000087 | Hc Inc Impltj Crnl Nrv Nstim Eltrds & Pulse Gener | $82,351 | $53,528 | — | — | 0 |
| 36000083 | Hc Insj/Rplcmt Cranial Neurostim Gener 2/> Eltrds | $73,741 | $47,932 | — | — | 0 |
| 36100784_50 | Hc Athrodesis Sacroiliac Joint W Img Guidance | $69,857 | $45,407 | — | — | 0 |
| RX-189668 | LUSPATERCEPT-AAMT 75 MG SUBCUTANEOUS SOLUTION | $61,601 | $40,041 | — | — | 0 |
| 27800045 | Hc Yttrium-90 Nonstranded Per Source | $58,209 | $37,836 | — | — | 0 |
| RX-191683 | PERTUZUMAB 1,200 MG-TRASTUZUMAB 600 MG-HYALURON-ZZXF/15 ML SUBCUT SOLN | $57,809 | $37,576 | — | — | 0 |
| L_25074099 | Noncdm Charge Record Pharmacy | $50,602 | $32,892 | — | — | 0 |
| RX-194425 | DOSTARLIMAB-GXLY 50 MG/ML INTRAVENOUS SOLUTION | $49,985 | $32,490 | — | — | 0 |
| 36000082 | Hc Ins/Repl Cranl Nstim Pg/Rcvr W 1 Elctr Array | $49,808 | $32,375 | — | — | 0 |
| RX-178229 | ATEZOLIZUMAB 1,200 MG/20 ML (60 MG/ML) INTRAVENOUS SOLUTION | $48,156 | $31,301 | — | — | 0 |
| 27200393 | Hc Aspiration Embolectomy System | $47,551 | $30,908 | — | — | 0 |
| RX-186317 | CEMIPLIMAB-RWLC 50 MG/ML INTRAVENOUS SOLUTION | $47,099 | $30,615 | — | — | 0 |
| RX-169212 | VEDOLIZUMAB 300 MG INTRAVENOUS SOLUTION | $46,735 | $30,378 | — | — | 0 |
| 27200472 | Hc Vad Cardiohelp (Hls Set Advanced 7.0) | $45,192 | $29,375 | — | — | 0 |
| L_25074090 | Noncdm Charge Record Pharmacy | $44,056 | $28,637 | — | — | 0 |
| RX-191098 | DARATUMUMAB 1,800 MG-HYALURONIDASE-FIHJ 30,000 UNIT/15 ML SUBCUT SOLN | $43,716 | $28,415 | — | — | 0 |
| 36100532 | Hc Implant Or Replace Programmable Pump | $41,388 | $26,902 | — | — | 0 |
| 27200401 | Hc Blood Pump Disposable | $41,319 | $26,858 | — | — | 0 |
| L_25074089 | Noncdm Charge Record Pharmacy | $41,274 | $26,828 | — | — | 0 |
| RX-191684 | PERTUZUMAB 600 MG-TRASTUZUMAB 600 MG-HYALURONID-ZZXF/10 ML SUBCUT SOLN | $38,565 | $25,067 | — | — | 0 |
| RX-167037 | OBINUTUZUMAB 1,000 MG/40 ML INTRAVENOUS SOLUTION | $37,416 | $24,321 | — | — | 0 |
| RX-9002 | ALTEPLASE 100 MG INTRAVENOUS SOLUTION | $35,757 | $23,242 | — | — | 0 |
| 36100784 | Hc Athrodesis Sacroiliac Joint W Img Guidance | $34,928 | $22,703 | — | — | 0 |
| RX-184466 | TENECTEPLASE 50 MG INTRAVENOUS SOLUTION | $32,115 | $20,875 | — | — | 0 |
| RX-108057 | PANITUMUMAB 400 MG/20 ML (20 MG/ML) INTRAVENOUS SOLUTION | $29,456 | $19,146 | — | — | 0 |
| RX-116596 | PERTUZUMAB 420 MG/14 ML (30 MG/ML) INTRAVENOUS SOLUTION | $28,374 | $18,443 | — | — | 0 |
| RX-199259 | MIRVETUXIMAB SORAVTANSINE-GYNX 5 MG/ML INTRAVENOUS SOLUTION | $28,216 | $18,340 | — | — | 0 |
| RX-182001 | RITUXIMAB 1,400 MG/11.7 ML (120 MG/ML)-HYALURONIDASE SUBCUTANEOUS SOLN | $27,362 | $17,786 | — | — | 0 |
| 36000085 | Hc Perc Impltj Neurostimulator Eltrd Cranial Nerve | $27,304 | $17,748 | — | — | 0 |
| 36100540 | Hc Ins Or Repl Spinal Neurostim Pulse Gen | $26,853 | $17,454 | — | — | 0 |
| 75000174 | Hc Bronchoscopy By Microwave Energy | $26,667 | $17,334 | — | — | 0 |
| 27400098 | Hc Power Module | $26,234 | $17,052 | — | — | 0 |
| 27800274 | Hc Kit Sprint Pns Extensa Dual Lead | $25,578 | $16,626 | — | — | 0 |
| RX-172084 | PEMBROLIZUMAB 25 MG/ML INTRAVENOUS SOLUTION | $25,036 | $16,273 | — | — | 0 |
| 27400099 | Hc Battery Charger | $23,612 | $15,348 | — | — | 0 |
| RX-31432 | DIGOXIN IMMUNE FAB 40 MG INTRAVENOUS SOLUTION | $23,099 | $15,014 | — | — | 0 |
| L_25070346 | Noncdm Charge Record Pharmacy | $22,742 | $14,782 | — | — | 0 |
| RX-172899 | OCTREOTIDE,MICROSPHERES ER 20 MG INTRAMUSCULAR SUSP, EXTENDED RELEASE | $22,318 | $14,507 | — | — | 0 |
| L_25073791 | Noncdm Charge Record Pharmacy | $22,125 | $14,381 | — | — | 0 |
| RX-196554 | TEZEPELUMAB-EKKO 210 MG/1.91 ML (110 MG/ML) SUBCUTANEOUS SYRINGE | $21,830 | $14,190 | — | — | 0 |
| 36100491_50 | Hc Reopen Fallopian Tube | $21,470 | $13,956 | — | — | 0 |
| 48100027 | Hc Coronary Angiogrphy W Byp Grfts Lhc And Rhc | $21,101 | $13,716 | — | — | 0 |
| 36100445_50 | Hc Rem And Repl Ureteral Stent Transurethral | $20,810 | $13,527 | — | — | 0 |
| 36100459_50 | Hc Cryoablation Renal Tumor Unilat | $20,708 | $13,460 | — | — | 0 |
| 36100444_50 | Hc Rem Ureteral Stent Perc | $20,654 | $13,425 | — | — | 0 |
| 36100447_50 | Hc Rem And Repl Transnephric Ureteral Stent | $20,654 | $13,425 | — | — | 0 |
| RX-189667 | LUSPATERCEPT-AAMT 25 MG SUBCUTANEOUS SOLUTION | $20,556 | $13,361 | — | — | 0 |
| L_36026847 | Noncdm Charge Record Medical Supplies | $20,506 | $13,329 | — | — | 0 |
Showing top 50 of 15,536 priced procedures, sorted by gross charge.
Data straight from this hospital's federally-mandated machine-readable file (45 CFR § 180). The compliance grade reflects how completely the hospital published the six required data elements, not the quality of care.